Complexo Hospitalario Universitario de Lugo
Care center
Hospital de Sabadell
Barcelona, EspañaPublications in collaboration with researchers from Hospital de Sabadell (3)
2016
-
Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome
Critical Care, Vol. 20, Núm. 1
-
Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study
BMC Cancer, Vol. 16, Núm. 1
2010
-
Cetuximab given every 2 weeks plus irinotecan is an active and safe option for previously treated patients with metastatic colorectal cancer
Chemotherapy, Vol. 56, Núm. 2, pp. 142-146